首页> 外国专利> TARGETED KNOCKOUT OF HUMAN PDCD1L1 GENE BASED ON CRISPR/CAS9 AND SPECIFIC GRNA OF HUMAN PDCD1L1 GENE

TARGETED KNOCKOUT OF HUMAN PDCD1L1 GENE BASED ON CRISPR/CAS9 AND SPECIFIC GRNA OF HUMAN PDCD1L1 GENE

机译:基于人PDCD1L1基因CRISPR / CAS9和特定GRNA的人PDCD1L1基因的靶向敲除

摘要

Provided are CRISPR/Cas9 system-based directed RNA(gRNA) sequences and combinations thereof in preparation of gRNA for specifically targeted knockout of the human PDCD1L1 gene. The gRNA is designed according to a CRISPR/Cas9 design principle, the sequence of the gRNA is as shown in SEQ ID NO.1, and the gRNA is constructed on a px459 vector. In Jurkat cells, the CRISPR/Cas9 system directed by the gRNA and combination thereof can effectively knock out the human PDCD1L1 gene. The prepared gRNA can accurately target the human PDCD1L1 gene and implement a gene knockout. The preparation method is simple in operation, the gRNA is good in targeting, and knockout efficiency of the CRISPR/Cas9 system is high.
机译:提供基于CRISPR / Cas9系统的定向RNA(gRNA)序列及其组合,以制备用于特异性靶向敲除人PDCD1L1基因的gRNA。根据CRISPR / Cas9设计原理设计gRNA,gRNA的序列如SEQ ID NO.1所示,并且在px459载体上构建gRNA。在Jurkat细胞中,由gRNA及其组合指导的CRISPR / Cas9系统可以有效敲除人PDCD1L1基因。制备的gRNA可以准确地靶向人PDCD1L1基因并实现基因敲除。该制备方法操作简单,gRNA靶向性好,CRISPR / Cas9系统的敲除效率高。

著录项

  • 公开/公告号WO2019237393A1

    专利类型

  • 公开/公告日2019-12-19

    原文格式PDF

  • 申请/专利权人 SHENZHEN BIOCAN TECHNOLOGIES CO. LTD.;

    申请/专利号WO2018CN91723

  • 发明设计人 MAO JIYAN;

    申请日2018-06-16

  • 分类号C12N5/10;C12N15/867;C12N15/12;A01K67/027;A61K49;A61K39/395;

  • 国家 WO

  • 入库时间 2022-08-21 11:14:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号